Clinical trial
Upadacitinib for Refractory Behcet's Syndrome: a Prospective Pilot Open-label Study
NCT07080346 is registered in ClinicalTrials.gov with Liu Tian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Upadacitinib for Refractory Behcet's Syndrome: a Prospective Pilot Open-label Study
- Lead sponsor
- Liu Tian
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 25, 2024
- Completion date
- July 8, 2025
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.